Finally, SARS-CoV2 has been reported to be a hepcidin mimetic [28,29] and was believed to target hemoglobin [7], in which case tocilizumab could have produced the normalization of plasma iron without an effect on ferritin, hepcidin and anemia. Here, HAMP is linked to anemia (phenotype).